| Ketamine for Suicidality in Bipolar Depression (NCT01944293) | New York State Psychiatric Institute | 2013-09-01 |
| Personalized and Scalable Cognitive Remediation Approaches (NCT01945333) | New York State Psychiatric Institute | 2013-09-01 |
| Effects of Nicotine Replacement Therapy and D-cycloserine on Nicotine Treatment Seekers (NCT01907594) | New York State Psychiatric Institute | 2013-08-01 |
| A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults (NCT01942187) | New York State Psychiatric Institute | 2013-08-01 |
| Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence (NCT01811940) | New York State Psychiatric Institute | 2013-07-01 |
| Gabapentin Treatment of Benzodiazepine Dependence (NCT01893632) | New York State Psychiatric Institute | 2013-07-01 |
| Cognitive Behavior Therapy for Depression (NCT01868711) | New York State Psychiatric Institute | 2013-07-01 |
| The Effect of Glutamatergic Modulation on Cocaine Self-administration (NCT02596022) | New York State Psychiatric Institute | 2013-06-01 |
| TDCS for Auditory Hallucinations in Schizophrenia (NCT01898299) | New York State Psychiatric Institute | 2013-05-01 |
| NMDA Antagonists in Bipolar Depression (NCT01833897) | New York State Psychiatric Institute | 2013-03-01 |
| Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior (NCT01826240) | New York State Psychiatric Institute | 2013-03-01 |
| Critical Time Intervention for Individuals With Hoarding Disorder (NCT02367430) | New York State Psychiatric Institute | 2013-01-01 |
| Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo (NCT01920802) | New York State Psychiatric Institute | 2012-11-01 |
| Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers (NCT01740414) | New York State Psychiatric Institute | 2012-11-01 |
| Attaining and Maintaining Wellness in Obsessive-compulsive Disorder (NCT01686087) | New York State Psychiatric Institute | 2012-10-01 |
| Quetiapine Pharmacotherapy for Cannabis Dependence (NCT01697709) | New York State Psychiatric Institute | 2012-10-01 |
| Kuvan in People With Schizophrenia and Schizoaffective Disorder (NCT01706965) | New York State Psychiatric Institute | 2012-10-01 |
| Cognitive Training for Memory Deficits Associated With Electroconvulsive Therapy (NCT01876758) | New York State Psychiatric Institute | 2012-09-01 |
| Developing New Clinical Management Strategies (NCT02082392) | New York State Psychiatric Institute | 2012-09-01 |
| Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults (NCT01869374) | New York State Psychiatric Institute | 2012-08-01 |
| Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil (NCT01845636) | New York State Psychiatric Institute | 2012-08-01 |
| Brazilian HIV/Sexually Transmitted Infection (STI) Prevention for Adolescents With Mental Health Disorder (NCT01854853) | New York State Psychiatric Institute | 2012-08-01 |
| Studying the Effects of Phentermine on Eating Behavior (NCT01886937) | New York State Psychiatric Institute | 2012-07-01 |
| Cognitive Skills Training for Homeless Youth (NCT01815398) | New York State Psychiatric Institute | 2012-07-01 |
| Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders (NCT03278938) | New York State Psychiatric Institute | 2012-06-29 |
| Ketamine in the Treatment of Suicidal Depression (NCT01700829) | New York State Psychiatric Institute | 2012-06-01 |
| Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD (NCT01695291) | New York State Psychiatric Institute | 2012-05-01 |
| The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia. (NCT01897064) | New York State Psychiatric Institute | 2012-04-01 |
| A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer (NCT01940237) | New York State Psychiatric Institute | 2012-04-01 |
| Desvenlafaxine vs. Placebo Treatment of Chronic Depression (NCT01537068) | New York State Psychiatric Institute | 2012-02-01 |
| Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence (NCT01467999) | New York State Psychiatric Institute | 2012-02-01 |
| The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence (NCT01535937) | New York State Psychiatric Institute | 2012-02-01 |
| Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence (NCT01486810) | New York State Psychiatric Institute | 2011-12-01 |
| Tranylcypromine Treatment of Bipolar Depression (NCT01430455) | New York State Psychiatric Institute | 2011-11-01 |
| Combination Treatment Study for Memory Impairment and Depression (NCT01658228) | New York State Psychiatric Institute | 2011-09-01 |
| A Stepped Care Model of Adolescent Depression Treatment in Primary Care (NCT01443715) | New York State Psychiatric Institute | 2011-09-01 |
| A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior (NCT01447602) | New York State Psychiatric Institute | 2011-09-01 |
| Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression (NCT01379781) | New York State Psychiatric Institute | 2011-08-01 |
| Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD (NCT01415440) | New York State Psychiatric Institute | 2011-08-01 |
| Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder (NCT02048241) | New York State Psychiatric Institute | 2011-07-01 |
| Wake Therapy in the Treatment of Depression (NCT01431573) | New York State Psychiatric Institute | 2011-07-01 |
| Improved Strategies for Outpatient Opioid Detoxification (NCT01377610) | New York State Psychiatric Institute | 2011-06-01 |
| Exercise, Age-Related Memory Decline, And Hippocampal Function (NCT01329653) | New York State Psychiatric Institute | 2011-06-01 |
| Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders (NCT01519557) | New York State Psychiatric Institute | 2011-04-01 |
| A Comparison of Long-acting Injectable Medications for Schizophrenia (NCT01136772) | New York State Psychiatric Institute | 2011-03-01 |
| Pioglitazone for Heroin and for Nicotine Dependence (NCT01395797) | New York State Psychiatric Institute | 2011-03-01 |
| Nalrexone Facilitated Discontinuation of Buprenorphine (NCT01895036) | New York State Psychiatric Institute | 2011-02-01 |
| Glutamatergic Modulation of Cocaine-related Deficits (NCT01790490) | New York State Psychiatric Institute | 2011-02-01 |
| Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172 (NCT01222351) | New York State Psychiatric Institute | 2010-12-01 |
| Alprazolam and Eating Behavior in Anorexia Nervosa (NCT01411813) | New York State Psychiatric Institute | 2010-11-01 |
| Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone (NCT01395784) | New York State Psychiatric Institute | 2010-08-01 |
| Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE) (NCT01437293) | New York State Psychiatric Institute | 2010-08-01 |
| HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment (NCT01383837) | New York State Psychiatric Institute | 2010-08-01 |
| Cognitive Benefits of Aerobic Exercise Across the Age Span (NCT01179958) | New York State Psychiatric Institute | 2010-08-01 |
| Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa (NCT01170117) | New York State Psychiatric Institute | 2010-08-01 |
| Gabapentin for Abstinence Initiation in Alcohol Dependence (NCT01141049) | New York State Psychiatric Institute | 2010-08-01 |
| Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone (NCT01173874) | New York State Psychiatric Institute | 2010-07-01 |
| Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study (NCT01748955) | New York State Psychiatric Institute | 2010-06-01 |
| Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning (NCT01783080) | New York State Psychiatric Institute | 2010-06-01 |
| Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients (NCT01134198) | New York State Psychiatric Institute | 2010-05-01 |
| Enhancing Attention in Adults With Compulsive Hoarding (NCT01100268) | New York State Psychiatric Institute | 2010-04-01 |
| Web-delivery of Evidence-based, Psychosocial Treatment for Substance Use Disorders (NCT01104805) | New York State Psychiatric Institute | 2010-04-01 |
| Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD) (NCT01100255) | New York State Psychiatric Institute | 2010-04-01 |
| Training Clinicians in Motivational Interviewing (NCT01065480) | New York State Psychiatric Institute | 2010-03-01 |
| A Study of Medication With or Without Psychotherapy for Complicated Grief (NCT01179568) | New York State Psychiatric Institute | 2010-03-01 |
| Dronabinol Naltrexone Treatment for Opioid Dependence (NCT01024335) | New York State Psychiatric Institute | 2010-01-01 |
| Psychological Symptoms Among Adolescents Enrolled in a Bariatric Surgery Program (NCT01079377) | New York State Psychiatric Institute | 2010-01-01 |
| Combined Pharmacotherapy for Cannabis Dependency (NCT01020019) | New York State Psychiatric Institute | 2010-01-01 |
| Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms (NCT01919216) | New York State Psychiatric Institute | 2010-01-01 |
| Exercise and Inflammation (NCT01335737) | New York State Psychiatric Institute | 2010-01-01 |
| Mars Flavanol Exercise and Cognitive Function Study (NCT01180127) | New York State Psychiatric Institute | 2009-12-01 |
| Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression (NCT01922219) | New York State Psychiatric Institute | 2009-12-01 |
| PET Biomarkers in Treatment Resistant Depression (NCT01031810) | New York State Psychiatric Institute | 2009-11-01 |
| Inpatient Exposure Therapy and Response Prevention & Cognitive Remediation Therapy for Anorexia Nervosa (NCT01174602) | New York State Psychiatric Institute | 2009-11-01 |
| Interpersonal Therapy for Depression in Breast Cancer (NCT01191580) | New York State Psychiatric Institute | 2009-10-01 |
| Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder (NCT00956085) | New York State Psychiatric Institute | 2009-08-01 |
| Study of Quetiapine Treatment for Cannabis Dependence (NCT00954681) | New York State Psychiatric Institute | 2009-08-01 |
| Cognitive-Motivational Behavior Therapy for Pathological Gamblers (NCT01135264) | New York State Psychiatric Institute | 2009-08-01 |
| Examining Common Substrates of Eating and Alcohol Use Disorders (NCT01172210) | New York State Psychiatric Institute | 2009-07-01 |
| Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone (NCT01760473) | New York State Psychiatric Institute | 2009-05-01 |
| Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder (NCT00834834) | New York State Psychiatric Institute | 2009-03-01 |
| Modafinil for Smoked Cocaine Self-Administration (NCT01778010) | New York State Psychiatric Institute | 2009-03-01 |
| Studying the Effects of Sibutramine on Eating Behavior (NCT01170364) | New York State Psychiatric Institute | 2009-02-01 |
| Characteristics and Importance of Physical Activity in Women With Anorexia Nervosa (NCT00917423) | New York State Psychiatric Institute | 2009-02-01 |
| The Efficacy of Parent Involvement in the Treatment of Adolescent Depression (NCT00883519) | New York State Psychiatric Institute | 2009-01-01 |
| Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression (NCT01754493) | New York State Psychiatric Institute | 2008-12-01 |
| Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy (NCT00791440) | New York State Psychiatric Institute | 2008-11-01 |
| Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism (NCT01983189) | New York State Psychiatric Institute | 2008-11-01 |
| Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal (NCT00723177) | New York State Psychiatric Institute | 2008-10-01 |
| D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD (NCT01172873) | New York State Psychiatric Institute | 2008-09-01 |
| Pilot Study of Minocycline (NPL-2003) in Adults With Obsessive-Compulsive Disorder (OCD) (NCT00728923) | New York State Psychiatric Institute | 2008-08-01 |
| Effect of Quetiapine on Marijuana Withdrawal and Relapse (NCT00743366) | New York State Psychiatric Institute | 2008-08-01 |
| Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics (NCT00742573) | New York State Psychiatric Institute | 2008-08-01 |
| Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa (NCT00670293) | New York State Psychiatric Institute | 2008-07-01 |
| Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS (NCT00737204) | New York State Psychiatric Institute | 2008-06-01 |
| Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers (NCT00743119) | New York State Psychiatric Institute | 2008-06-01 |
| Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (NCT00476242) | New York State Psychiatric Institute | 2008-06-01 |
| Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana (NCT00743145) | New York State Psychiatric Institute | 2008-05-01 |
| Effectiveness of Three Different Psychotherapies for Chronic Post-Traumatic Stress Disorder (NCT00739765) | New York State Psychiatric Institute | 2008-04-01 |
| Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse (NCT00573534) | New York State Psychiatric Institute | 2008-03-01 |